Morning Headlines 5/4/26 – Image for illustrative purposes only (Image credits: Pexels)
Waystar Holding Corp. posted first-quarter 2026 revenue of $313.9 million, a 22% rise compared to the prior year.[1][2] The healthcare technology firm also recorded net income of $43.3 million alongside an adjusted EBITDA of $135.4 million, which carried a 43% margin.[2] Strong execution in its revenue cycle management platform fueled these results as providers increasingly adopt standardized solutions.
Key Financial Metrics at a Glance
Subscription revenue led the charge at $172.2 million, surging 38% year-over-year and highlighting the shift toward recurring streams.[1] Volume-based revenue reached $139.5 million, up 7% from last year, while overall profitability metrics exceeded expectations.
The table below captures the standout figures:
| Metric | Q1 2026 | YoY Change |
|---|---|---|
| Revenue | $313.9 million | +22% |
| Net Income (GAAP) | $43.3 million | N/A |
| Adjusted EBITDA | $135.4 million | N/A |
| Net Income Margin | 14% | N/A |
Non-GAAP net income stood at $81.2 million, with diluted earnings per share of $0.42 on a non-GAAP basis.[2] These numbers reflect disciplined cost management and scalable operations.
Subscription Surge Signals Platform Momentum
Waystar’s net revenue retention rate hit 111%, demonstrating client stickiness in healthcare payments processing.[1] The company now counts 1,433 clients generating more than $100,000 in last-twelve-months revenue, a 15% increase year-over-year.
Executives pointed to platform expansion as a core driver. “Waystar delivered a solid first quarter, driven by strong execution and continued expansion across our platform,” said Matt Hawkins, chief executive officer.[2] This performance underscores the value providers place on integrated solutions for claims and payments.
Innovations and Integrations Fuel Expansion
The firm advanced its integration with Iodine, enhancing data capabilities within its ecosystem. New launches included an AI-powered recoupment solution designed to recover underpayments more efficiently.
Bookings exceeded internal targets, bolstering confidence in market adoption. Cash generation remained healthy, with operating cash flow at $84.9 million and unlevered free cash flow at $90.3 million.[2] On the balance sheet, cash and equivalents totaled $34.3 million, with net debt at $1.32 billion and an adjusted net leverage ratio of 2.7 times.
These developments position Waystar to capture more share in a fragmented industry.
Confident Guidance for Full-Year 2026
Management raised its outlook, projecting full-year revenue between $1.274 billion and $1.294 billion. Adjusted EBITDA guidance sits at $530 million to $540 million, with non-GAAP net income expected from $317 million to $335 million.[1]
Diluted non-GAAP net income per share is forecasted at $1.59 to $1.68. Hawkins added that these bookings trends “reinforce our confidence as providers increasingly standardize on Waystar.”[2] The guidance assumes normalized organic growth around 10%, aligning with long-term targets.
Waystar’s Q1 momentum suggests sustained leadership in healthcare revenue management. As AI tools and integrations mature, the company appears poised to navigate sector challenges while delivering shareholder value through the year.
